BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Down 77.3% in December

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 2,900 shares, a drop of 77.3% from the November 30th total of 12,800 shares. Based on an average trading volume of 158,000 shares, the days-to-cover ratio is currently 0.0 days.

BriaCell Therapeutics Trading Down 9.2 %

Shares of BriaCell Therapeutics stock traded down $0.03 during trading on Thursday, reaching $0.27. The company’s stock had a trading volume of 115,445 shares, compared to its average volume of 86,500. BriaCell Therapeutics has a one year low of $0.11 and a one year high of $2.60. The business’s fifty day moving average price is $0.34 and its 200-day moving average price is $0.29.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.